Partnership Expansion mySugr has a history of successful integrations with major industry players like Novo Nordisk and Roche. Leveraging these existing partnerships could lead to new collaboration opportunities and increased market presence.

Acquisition Potential Having been acquired by Roche, mySugr stands as an attractive target for companies looking to enhance their digital diabetes management offerings. Exploring acquisition possibilities with strategic partners could be a valuable sales avenue.

Tech Integration Opportunities With a tech stack including Salesforce, Google Docs, Oracle, and more, mySugr is well-equipped to integrate with a wide range of systems. Highlighting the compatibility of mySugr's technology with potential clients' existing platforms could drive sales.

Market Collaboration As a specialist in diabetes care, mySugr has the expertise to collaborate with organizations managing populations with diabetes, offering mutual benefits. Seeking out partnerships with healthcare providers or insurers could open up new markets for mySugr's solutions.

Competitive Advantage Positioned alongside notable competitors like Noom and Medtronic, mySugr's focus on app-based diabetes care could be a unique selling point. Highlighting the distinct advantages of mySugr's offerings in comparison to competitors can strengthen sales pitches.